Drug, bio-affecting and body treating compositions

YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS Y10USPC classification Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10S424/00Drug, bio-affecting and body treating compositions

Y10S424/01Aerosol hair preparation Y10S424/02Resin hair settings Y10S424/03Hair bleach Y10S424/04Dandruff Y10S424/05Stick Y10S424/06Chelate Y10S424/07Microporous membranes Y10S424/08Systemic pesticides Y10S424/09Fish posts Y10S424/10Insect repellent Y10S424/11Termite treating Y10S424/12Fertilization attaching inhibition Y10S424/13Burn treatment Y10S424/14Topical contraceptives and spermacides Y10S424/15Suppositories Y10S424/16Dendrimers and dendritic polymers Y10S424/80Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part Y10S424/801involving antibody or fragment thereof produced by recombinant dna technology Y10S424/802Antibody or antigen-binding fragment thereof that binds gram-positive bacteria Y10S424/803Antibody or antigen-binding fragment thereof that binds gram-negative bacteria Y10S424/804involving IgG3, IgG4, IgA, or IgY Y10S424/805involving IgE or IgD Y10S424/806involving IgM Y10S424/807Monoclonal Y10S424/808Human Y10S424/809involving immunoglobulin or antibody fragment Y10S424/81involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy Y10S424/811involving sex selection or contraception Y10S424/812Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector Y10S424/813Viral vaccine for bovine species Y10S424/814Viral vaccine for ovine species Y10S424/815Viral vaccine for porcine species Y10S424/816Viral vaccine for avian species Y10S424/817Viral vaccine for fish Y10S424/818Viral vaccine for canidae or mustelidae Y10S424/819Viral vaccine for feline species Y10S424/82Viral vaccine for equine species Y10S424/821involving temperature-sensitive mutant virus Y10S424/822involving tk- virus Y10S424/823Bacterial vaccine for bovine species Y10S424/824Bacterial vaccine for ovine species Y10S424/825Bacterial vaccine for porcine species Y10S424/826Bacterial vaccine for avian species Y10S424/827Bacterial vaccine for fish Y10S424/828Bacterial vaccine for canidae or mustelidae Y10S424/829Bacterial vaccine for equine species Y10S424/83involving temperature-sensitive mutant bacterium Y10S424/831involving capsular polysaccharide of bacterium Y10S424/832involving bacterial toxin that has modified amino acid sequence Y10S424/90In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient